TRLV insider buying & filings

TRLVTrulieve Cannabis Corp.

NYSE · Healthcare · $1.68B

$8.75

-2.78% · Aug 7

7 insider filings on record.
None of them an open-market buy in the last year.

Last Form 4 Jun 26 · scanned 3h ago

Price · 1Y · daily● 7 sells

▸ hover a marker for the filing · drag to zoom · 4 moves explained

AI brief · from the filings on this pagePro

The filings, the score and the setup on this page, read for you in about ten seconds — what the insiders did, and what stands against it.

Market cap

$1.68B

Float

167.6M

99% public

Short % float

Pro

Price / profit

—

not yet profitable

Price / future profit

36.5

Price / sales

1.4

Institutional stakes

▸ a holder crossing 5% files Schedule 13D if they intend to act on the company, 13G if they certify they will not · /A amends an earlier filing

1 filingnewest first

13GAdvisorShares Trust6.3%Jul 8

The record

newest first

DateTypeInsiderOf stakeShares @ priceValue

Jun 26SELLRivers Kim A.10%Chairman and CEOdirect136,811 @ $8.76$1.20M

Jun 25SELLRivers Kim A.10%Chairman and CEOdirect300,000 @ $8.17$2.45M

Jun 25SELLRivers Kim A.10%Chairman and CEOdirect400,000 @ $8.17$3.27M

Jun 25SELLRivers Kim A.10%Chairman and CEOdirect380,000 @ $8.47$3.22M

Jun 22SELLRivers Kim A.10%Chairman and CEOdirect204,815 @ $9.35$1.92M

The file stays open

▸ SEC EDGAR · FINRA · Nasdaq — public sources only · research, not advice